Mark Allen

Mark Allen

Company: Elevian

Job title: Chief Executive Officer


Dr. Allen is Co-Founder and CEO of Elevian, a preclinical stage biotech developing therapeutics that target aging.  Dr. Allen is a serial entrepreneur and executive, with experience leading organizations from inception to profitable growth to successful exit. Most recently, Dr. Allen was the Founder & CEO of Corticon, sold to Progress (NASD: PRGS), a leading rules engine powering automated decision-making in healthcare, retail, government and financial services. A member of YPO since 2009 and officer of YPO SF Gold, Dr. Allen has a BS in Applied Physics from Columbia University and an MD from UCLA.


Explore the Role of Growth Differentiation Factor 11 (GDF11) in Aging & Rejuvenation 4:00 pm

Summary of GDF11 implications in the scientific field Drugifying GDF11 Examine the influence of GDF11 on brain fate and function and its compelling indications Discuss future directionsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.